Management ChangeJun 22, 2026, 09:51 AM
Revium Rx COO & President Inna Martin Resigns
AI Summary
Revium Rx announced the resignation of Ms. Inna Martin from her roles as Director, Chief Operating Officer, and President, effective June 16, 2026. Her departure was attributed to differences in expectations between her and the Company. In connection with her resignation, a Separation Agreement was executed, terminating her employment and consultancy on September 10, 2026, and extending the exercise period for her 2,440,000 vested stock options until September 30, 2028.
Key Highlights
- Ms. Inna Martin resigned as Director, Chief Operating Officer, and President of Revium Rx.
- Her resignation was effective immediately on June 16, 2026.
- The departure was due to "differences in expectations" between her and the Company.
- Her employment and consultancy with Revium Ltd. will terminate on September 10, 2026.
- The exercise period for her vested stock options (2,440,000 shares) was extended to September 30, 2028.
Price Impact
More from RVRC